Abstract
The synthesis and antiribosomal and antibacterial activity of both anomers of a novel apralog, 5-O-(5-amino-3-C-dimethylaminopropyl-D-ribofuranosyl)apramycin, are reported. Both anomers show excellent activity for the inhibition of bacterial ribosomes and that of MRSA and various wild-type Gram negative pathogens. The new compounds retain activity in the presence of the aminoglycoside phosphoryltransferase aminoglycoside modifying enzymes that act on the primary hydroxy group of typical 4,5-(2-deoxystreptamine)-type aminoglycoside and related apramycin derivatives. Unexpectedly, the two anomers have comparable activity both for the inhibition of bacterial ribosomes and of the various bacterial strains tested.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference54 articles.
1. Development of Aminoglycoside Antibiotics Effective against Resistant Bacterial Strains;Yang;Curr. Top. Med. Chem.,2010
2. Molecular Insights into Aminoglycoside Action and Resistance;Magnet;Chem. Rev.,2005
3. Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives;Labby;Med. Chem. Commun.,2016
4. Zárate, S.G., De la Cruz Claure, M.L., Benito-Arenas, R., Revuelta, R., Santana, A.G., and Bastida, A. (2018). Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors. Molecules, 23.
5. Dissociation of Antibacterial Activity and Aminoglycoside Ototoxicity in the 4-Monosubstituted 2-Deoxystreptamine Apramycin;Matt;Proc. Natl. Acad. Sci. USA,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献